Lyell Immunopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LYEL and other ETFs, options, and stocks.About LYEL
Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D.
CEOLynn Seely
CEOLynn Seely
Employees300
Employees300
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2018
Founded2018
Employees300
Employees300
LYEL Key Statistics
Market cap219.20M
Market cap219.20M
Price-Earnings ratio-0.47
Price-Earnings ratio-0.47
Dividend yield—
Dividend yield—
Average volume23.88K
Average volume23.88K
High today$11.56
High today$11.56
Low today$11.21
Low today$11.21
Open price$11.50
Open price$11.50
Volume7.36K
Volume7.36K
52 Week high$32.00
52 Week high$32.00
52 Week low$7.65
52 Week low$7.65
LYEL News
TipRanks 1d
Lyell announces initiation of Phase 3 head-to-head CAR T-cell therapy trialLyell Immunopharma (LYEL) announced the initiation of PiNACLE – H2H, a Phase 3 head-to-head CAR T-cell therapy randomized controlled trial and the formation of...
People also own
Based on the portfolios of people who own LYEL. This list is generated using Robinhood data, and it’s not a recommendation.